Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.
- DOI
- 10.1016/j.urolonc.2020.07.020
- Published
- 2020 Oct
- Container
- Urologic oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.urolonc.2020.07.020,
title = {Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.},
author = {Gaillard V and Tricard T and Garnon J and Cazzato RL and Dalili D and Gangi A and Lang H},
year = {2020},
journal = {Urologic oncology},
doi = {10.1016/j.urolonc.2020.07.020},
url = {https://doi.org/10.1016/j.urolonc.2020.07.020}
}RIS
TY - JOUR TI - Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes. AU - Gaillard V AU - Tricard T AU - Garnon J AU - Cazzato RL AU - Dalili D AU - Gangi A AU - Lang H PY - 2020 JO - Urologic oncology DO - 10.1016/j.urolonc.2020.07.020 UR - https://doi.org/10.1016/j.urolonc.2020.07.020 ER -
APA
V, G., T, T., J, G., RL, C., D, D., A, G., & H, L. (2020). Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2020.07.020
Source records
- pubmed · retrieved 2026-09-26T23:35:07.449Z